Liposarcoma of the thyroid

Sarcoma

Volumn 8, Issue 2-3, 2004, Pages 91-96

  Mitra, A ^a,c   Fisher, C ^b   Rhys Evans, P ^b   Harmer, C ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Liposarcoma; Thyroid

Indexed keywords

ADULT; AGED; BEAM THERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIPOSARCOMA; MALE; METASTASIS; MYXOSARCOMA; PRIORITY JOURNAL; RADIATION DOSE; RARE DISEASE; REVIEW; THYROID LIPOSARCOMA; THYROID TUMOR;

EID: 10844278163     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1357-7140400001517     Document Type: Review

References (22)

1. Baloch ZW, LiVolsi VA. Newly described tumours of the thyroid. Current Diagnostic Pathology (2000) 6, 151-164 Harcourt Publishers Ltd.
2. Cook AM, Vini L, Harmer C. Squamous cell carcinoma of the thyroid gland: outcome of treatment in 16 patients. Europ J Surg Onc 1999; 25: 606-609.
3. Andrion A, Gaglio A, Dogliani N, Bosco E, Mazzucco G. Liposarcoma of the Thyroid Gland. Am J Clin Path 1991; 95: 675-679.
4. Enzinger FM, Weiss SW. Liposarcoma. In: Enzinger FM, Weiss SW, eds. Soft tissue tumors. St. Louis: Mosby-Year Book, 1994: 431-66.
5. Weiss S. Histological Typing of Soft Tissue Tumours Editors, Springer-Verlag. 1994.
6. Rosai J, Carcangiu M, Delellis R, Tumours of the Thyroid Gland. Armed Forces Inst. Of Pathology. Washington DC.
7. Suster S, Fischer C. Immunoreactivty for the human progenitor cell antigen CD34 in lipomatous tumours: Am J Surg Path 1997; 21: 195-200.
8. Neilsen VT, et al. Liposarcoma of the Thyroid Gland. Tumori 1986; 72: 499-502.
9. Griem KL, Robb PK, et al. Radiation Induced Sarcoma of the Thyroid. Arch Otolaryngol Head Neck Surgery 1989; 115: 8, 991-993.
10. Eeles RA, Fisher C, A'Hern RP, Robinson M, Rhys-Evans P, Henk JM, Archer D, Harmer C. Head and Neck Sarcomas: prognostic factors and implications of treatment. Br J Cancer 1991, 68, 201-207.
11. Harmer C, Bidmead M, Shepherd S, Sharpe A, Vini L. Radiotherapy planning techniques for thyroid Cancer. Brit J Radiol 1998; 71: 1069-1075.
12. Nutting CM, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radioth Oncol 2001; 60: 173-180.
13. Harmer C, Bidmead M. Three-dimensional planning and conformal radiotherapy. J. Verwell, HM Pinedo and HD Suit, eds. In: Soft Tissue Sarcomas: Present Achievements and Future Prospects. Kluwer academic publishers, Boston 1997: 129-141.
14. O'Sullivan, et al. Pre-operative versus post-operative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet., 2002; vol 359 (Jun29): 2235-2241.
15. Suit HD, Proppe KH, Mankin HG, Wood WC. Pre-operative radiation therapy for sarcoma of soft tissue. Cancer 1981; 5: 2269-2274.
16. Pollack A, Zagars G, Goswitz M, et al. Pre-operative versus post-operative radiotherapy in the treatment of soft tissue sarcoma: a matter of presentation. Int J Radiat Oncol Biol Phys 1998; 42: 563.
17. Shiu MH, Turnbull AD, et al. Control of locally advanced extremity soft tissue sarcomas by function saving resection and brachytherapy. Cancer 1984; 53: 1385-1392
18. Jacob R, Gilligan D, Robinson M, Harmer C. Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy. Sarcoma 1999; 3: 157-165.
19. Sarcoma meta-analysis collaboration. Adjuvant chemotherapy for localised respectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997; 350: 1647-54.
20. Bramwell V, Rousesse J, Steward W, et al. Adjuvant CyVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organisation for Research and Treatment of Cancer, Soft tissue and Bone sarcoma Group. J Clin Onc 1994; 12: 1137.
21. Santoro A, Tursz T, Mourisden H, et al. Doxorubicin versus CyVADIC versus Doxorubicin and ifosfamide in first line treatment of advanced soft tissue sarcomas: a randomised study of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone sarcoma Group. J Clin Oncol 1995; 13: 1537.
22. Edmonson JH, Ryan LM, Blum RH, et al. Randomised comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993; 11: 1269.